Literature DB >> 12933905

GREAT/LGR8 is the only receptor for insulin-like 3 peptide.

Natalia V Bogatcheva1, Anne Truong, Shu Feng, Wolfgang Engel, Ibrahim M Adham, Alexander I Agoulnik.   

Abstract

During male development testes descend from their embryonic intraabdominal position into the scrotum. Two genes, encoding the insulin-like 3 peptide (INSL3) and the GREAT/LGR8 G protein-coupled receptor, control the differentiation of gubernaculum, the caudal genitoinguinal ligament critical for testicular descent. It was established that the INSL3 peptide activates GREAT/LGR8 receptor in vitro. Mutations of Insl3 or Great cause cryptorchidism (undescended testes) in mice. Overexpression of the transgenic Insl3 causes male-like gubernaculum differentiation, ovarian descent into lower abdominal position, and reduced fertility in females. To address the question whether Great deletion complements the mutant female phenotype caused by the Insl3 overexpression, we have produced Insl3 transgenic mice deficient for Great. Such females had a wild-type phenotype, demonstrating that Great was the only cognate receptor for Insl3 in vivo. We have established that pancreatic HIT cells, transfected with the INSL3 cDNA, produce functionally active peptide. Analysis of five INSL3 mutant variants detected in cryptorchid patients showed that P49S substitution renders functionally compromised peptide. Therefore, mutations in INSL3 might contribute to the etiology of cryptorchidism. We have also showed that synthetic insulin-like peptides (INSL4 and INSL6) were unable to activate LGR7 or GREAT/LGR8.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933905     DOI: 10.1210/me.2003-0096

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  41 in total

Review 1.  Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.

Authors:  M L Halls; E T van der Westhuizen; R A D Bathgate; R J Summers
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

2.  Characterization of relaxin receptor (RXFP1) desensitization and internalization in primary human decidual cells and RXFP1-transfected HEK293 cells.

Authors:  András Kern; Gillian D Bryant-Greenwood
Journal:  Endocrinology       Date:  2008-12-30       Impact factor: 4.736

3.  Origin of INSL3-mediated testicular descent in therian mammals.

Authors:  Jae-Il Park; Jenia Semyonov; Chia Lin Chang; Wei Yi; Wesley Warren; Sheau Yu Teddy Hsu
Journal:  Genome Res       Date:  2008-05-07       Impact factor: 9.043

4.  Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.

Authors:  Sabine Hombach-Klonisch; Joanna Bialek; Bogusz Trojanowicz; Ekkehard Weber; Hans-Jürgen Holzhausen; Josh D Silvertown; Alastair J Summerlee; Henning Dralle; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 5.  Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside.

Authors:  Alberto Ferlin; Luca De Toni; Marco Sandri; Carlo Foresta
Journal:  Br J Pharmacol       Date:  2016-05-05       Impact factor: 8.739

6.  In vitro degradation of insulin-like peptide 3 by insulin-degrading enzyme.

Authors:  Wei-Jie Zhang; Xiao Luo; Zhan-Yun Guo
Journal:  Protein J       Date:  2010-02       Impact factor: 2.371

Review 7.  The biology of infertility: research advances and clinical challenges.

Authors:  Martin M Matzuk; Dolores J Lamb
Journal:  Nat Med       Date:  2008-11-06       Impact factor: 53.440

8.  INSL3 in the ruminant: a powerful indicator of gender- and genetic-specific feto-maternal dialogue.

Authors:  Ravinder Anand-Ivell; Stefan Hiendleder; Carolina Viñoles; Graeme B Martin; Carolyn Fitzsimmons; Andrea Eurich; Bettina Hafen; Richard Ivell
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

9.  Relaxin signaling activates peroxisome proliferator-activated receptor gamma.

Authors:  Sudhir Singh; Robert G Bennett
Journal:  Mol Cell Endocrinol       Date:  2009-08-25       Impact factor: 4.102

10.  Identification of small-molecule agonists of human relaxin family receptor 1 (RXFP1) by using a homogenous cell-based cAMP assay.

Authors:  Catherine Z Chen; Noel Southall; Jingbo Xiao; Juan J Marugan; Marc Ferrer; Xin Hu; Raisa E Jones; Shu Feng; Irina U Agoulnik; Wei Zheng; Alexander I Agoulnik
Journal:  J Biomol Screen       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.